Loading interface...

Isolazine Tablet

Manufactured byLupin Ltd.
ContainsIsosorbide Dinitrate (20 mg) + Hydralazine (37.5 mg)
Description

Isolazine Tablet is a combination medicine used for the treatment of congestive heart failure. This medicine is not recommended for use in patients less than 18 years of age.

Side effects

Major & minor side effects for Isolazine Tablet

  • Bluish discoloration of lips, fingernails, palm, or hands
  • Low blood pressure
  • Dizziness and fainting
  • Headache
  • Nausea or Vomiting
  • Difficulty in swallowing
  • Hives and redness of skin
  • Burning or tingling sensation of hands and feet
  • Sleeplessness
  • Blurred vision
  • Skin rash/itching
  • Loss of appetite
  • Weight loss

Uses of Isolazine Tablet

What is it prescribed for?

  • Congestive Heart Failure
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed between 5-30 minutes of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 8 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol during treatment with this combination medicine may increase the risk of severe side effects. These side effects may include confusion, dizziness, nausea, vomiting, weakness, and fainting. It is advised that you should avoid alcohol and not to perform activities which require high mental alertness like driving a vehicle and operating machinery when taking these medicines together.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. Discuss all the risks and benefits with your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to isosorbide Dinitrate, Hydralazine, or any other ingredients present along with these medicines.

Anemia

This medicine is not recommended for use if you have anemia or low levels of hemoglobin in the blood due to the increased risk of worsening the patient's condition.

Medicine for erectile dysfunction

This medicine is not recommended for use if you are taking medicines for the treatment of erectile dysfunction. One of the most commonly used medicines for this condition is Viagra (sildenafil),
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. Discuss all the risks and benefits with your doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Fall in blood pressure

Use of this medicine can cause a fall in blood pressure in general and may make you feel dizzy especially while getting up from lying or sitting position (Postural hypotension).

Withdrawal symptoms

Abrupt discontinuation of this medicine may increase the risk of adverse effects. A gradual dose reduction is recommended to avoid these reactions. Do not stop the use of this medicine without consulting your doctor.

Nitrate free interval

The likelihood of the development of drug tolerance is very high if this medicine is taken very regularly. A minimal amount of nitrate-free time is required to avoid tolerance is 10-12 hr/day. The tolerance developed is in general for nitrates and may affect other medicines containing nitrates (cross-tolerance).

Driving and operating machinery

This medicine may cause symptoms such as dizziness, visual disturbances, fainting, weakness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during or immediately after receiving this medicine.

Use in children

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Systemic lupus erythematosus

Prolonged use of this medicine may increase the risk of systemic lupus erythematosus. The medicine should be discontinued under the doctor's supervision if the patient experiences any unusual reactions.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol during treatment with this combination medicine may increase the risk of severe side effects. These side effects may include confusion, dizziness, nausea, vomiting, weakness, and fainting. It is advised that you should avoid alcohol and not to perform activities which require high mental alertness like driving a vehicle and operating machinery when taking these medicines together.
Interaction with Medicine

Amisulpride

Amitriptyline

Aspirin

Riociguat

Tizanidine

Alprazolam

Diclofenac

Disease interactions

Hypotension

This medicine should be used with caution in patients suffering from hypotension (low blood pressure). Close monitoring of blood pressure levels is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Glaucoma

This medicine should be used with extreme caution in patients with a history of glaucoma (increased intraocular pressure) due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Liver Disease

This medicine should be used with extreme caution in patients suffering from liver diseases due to an increase in the risk of serious adverse effects. Close monitoring of liver function is advised while taking this medicine. Report any symptoms of confusion or jaundice to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine as instructed by the doctor. Do not take in larger or smaller quantities than recommended. The dosage and the duration of use of this medicine should be kept as low as possible. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This combination works by relaxing the blood vessels and reducing the pressure on the heart.
Legal Status

Approved

Approved

Unknown

Unknown

Classification

Category

Miscellaneous antihypertensive combinations

Schedule

Schedule H

DailyMed - BIDIL- hydralazine hydrochloride and isosorbide dinitrate tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 12 May 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00

[Internet]. Accessdata.fda.gov. 2020 [cited 12 May 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020727s005lbl.pdf

Isosorbide dinitrate - DrugBank [Internet]. Drugbank.ca. 2020 [cited 12 May 2020]. Available from:

https://www.drugbank.ca/drugs/DB00883

Hydralazine - DrugBank [Internet]. Drugbank.ca. 2020 [cited 12 May 2020]. Available from:

https://www.drugbank.ca/drugs/DB01275
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 12 May 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.